Imperial College London
Alternate

DrSanjayPopat

Faculty of Medicine, National Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Publication Type
Year
to

663 results found

Popat S, Liu SV, Scheuer N, Hsu GG, Lockhart A, Ramagopalan SV, Griesinger F, Subbiah Vet al., 2022, Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer, NATURE COMMUNICATIONS, Vol: 13

Journal article

Camidge DR, Kim HR, Ahn M-J, Yang JC-H, Han J-Y, Hochmair M, Lee KH, Delmonte A, Garcia Campelo R, Kim D-W, Griesinger F, Felip E, Califano R, Spira AI, Thomas M, Gettinger SN, Tiseo M, Liu Y, Zhang P, Popat Set al., 2022, Association of depth of target lesion response to brigatinib with outcomes in patients with ALK inhibitor-naive <i>ALK</i> plus NSCLC in ALTA-1L., Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Publisher: LIPPINCOTT WILLIAMS & WILKINS, ISSN: 0732-183X

Conference paper

Aravind P, Popat S, Barwick TD, Soneji N, Lythgoe M, Lozano-Kuehne J, Sreter KB, Bergqvist M, Patel NH, Aboagye EO, Kenny LMet al., 2022, [F-18]Fluorothymidine(FLT)-PET imaging of thymidine kinase 1 pharmacodynamics in non-small cell lung cancer treated with pemetrexed., ASCO, Publisher: LIPPINCOTT WILLIAMS & WILKINS, ISSN: 0732-183X

Conference paper

Popat S, Felip E, Kim ES, de Marinis F, Cho BC, Wermke M, De langen A, Ferrara R, Kanzler S, Cecere FL, Galetta D, Lee DH, Gregorc V, Rodrigues A, Britschgi C, Rahman A, Ndunda D, Noe J, Lu D, Besse Bet al., 2022, AcceleRET Lung: A phase 3 study of first-line pralsetinib in patients with <i>RET</i> fusion-positive advanced/metastatic NSCLC., Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Publisher: LIPPINCOTT WILLIAMS & WILKINS, ISSN: 0732-183X

Conference paper

Reckamp KL, Lin HM, Cranmer H, Wu Y, Zhang P, Walton LJ, Kay S, Cichewicz A, Neupane B, Fahrbach K, Popat S, Camidge DRet al., 2022, Indirect comparisons of brigatinib and alectinib for front-line <i>ALK</i>-positive non-small-cell lung cancer, FUTURE ONCOLOGY, Vol: 18, Pages: 2499-2510, ISSN: 1479-6694

Journal article

Coker EA, Stewart A, Ozer B, Minchom A, Pickard L, Ruddle R, Carreira S, Popat S, O'Brien M, Raynaud F, de Bono J, Al-Lazikani B, Banerji Uet al., 2022, Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic Changes, MOLECULAR CANCER THERAPEUTICS, Vol: 21, Pages: 1020-1029, ISSN: 1535-7163

Journal article

Zauderer MG, Szlosarek PW, Le Moulec S, Popat S, Taylor P, Planchard D, Scherpereel A, Koczywas M, Forster M, Cameron RB, Peikert T, Michaud NR, Szanto A, Yang J, Chen Y, Kansra V, Agarwal S, Fennell DAet al., 2022, EZH2 inhibitor tazemetostat in patients with relapsed or refractory, <i>BAP1</i>-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study, LANCET ONCOLOGY, Vol: 23, Pages: 758-767, ISSN: 1470-2045

Journal article

Popat S, Liu SV, Scheuer N, Gupta A, Hsu GG, Ramagopalan SV, Griesinger F, Subbiah Vet al., 2022, Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer, JAMA NETWORK OPEN, Vol: 5, ISSN: 2574-3805

Journal article

Scherpereel A, Antonia S, Bautista Y, Grossi F, Kowalski D, Zalcman G, Nowak AK, Fujimoto N, Peters S, Tsao AS, Mansfield AS, Popat S, Sun X, Lawrance R, Zhang X, Daumont MJ, Bennett B, McKenna M, Baas Pet al., 2022, First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743, LUNG CANCER, Vol: 167, Pages: 8-16, ISSN: 0169-5002

Journal article

Passaro A, Leighl N, Blackhall F, Popat S, Kerr K, Ahn MJ, Arcila ME, Arrieta O, Planchard D, de Marinis F, Dingemans AM, Dziadziuszko R, Faivre-Finn C, Feldman J, Felip E, Curigliano G, Herbst R, Janne PA, John T, Mitsudomi T, Mok T, Normanno N, Paz-Ares L, Ramalingam S, Sequist L, Vansteenkiste J, Wistuba II, Wolf J, Wu YL, Yang SR, Yang JCH, Yatabe Y, Pentheroudakis G, Peters Set al., 2022, ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer, ANNALS OF ONCOLOGY, Vol: 33, Pages: 466-487, ISSN: 0923-7534

Journal article

Whisenant JG, Baena J, Cortellini A, Huang L-C, Lo Russo G, Porcu L, Wong SK, Bestvina CM, Hellmann MD, Roca E, Rizvi H, Monnet I, Boudjemaa A, Rogado J, Pasello G, Leighl NB, Arrieta O, Aujayeb A, Batra U, Azzam AY, Unk M, Azab MA, Zhumagaliyeva AN, Gomez-Martin C, Blaquier JB, Geraedts E, Mountzios G, Serrano-Montero G, Reinmuth N, Coate L, Marmarelis M, Presley CJ, Hirsch FR, Garrido P, Khan H, Baggi A, Mascaux C, Halmos B, Ceresoli GL, Fidler MJ, Scotti V, Metivier A-C, Falchero L, Felip E, Genova C, Mazieres J, Tapan U, Brahmer J, Bria E, Puri S, Popat S, Reckamp KL, Morgillo F, Nadal E, Mazzoni F, Agustoni F, Bar J, Grosso F, Avrillon V, Patel JD, Gomes F, Ibrahim E, Trama A, Bettini AC, Barlesi F, Dingemans A-M, Wakelee H, Peters S, Horn L, Garassino MC, Torri Vet al., 2022, A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry, JOURNAL OF THORACIC ONCOLOGY, Vol: 17, Pages: 661-674, ISSN: 1556-0864

Journal article

Peters S, Scherpereel A, Cornelissen R, Oulkhouir Y, Greillier L, Kaplan MA, Talbot T, Monnet I, Hiret S, Baas P, Nowak AK, Fujimoto N, Tsao AS, Mansfield AS, Popat S, Zhang X, Hu N, Balli D, Spires T, Zalcman Get al., 2022, First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743, ANNALS OF ONCOLOGY, Vol: 33, Pages: 488-499, ISSN: 0923-7534

Journal article

O'Sullivan H, d'Arienzo PD, Yousaf N, Cui W, Popat Set al., 2022, Inadequacy of PCR genotyping in advanced non-small cell lung cancer: EGFR L747_A755delinsSS exon 19 deletion is not detected by the real-time PCR Idylla™ EGFR mutation test but is detected by ctDNA next generation sequencing and responds to osimertinib, EUROPEAN JOURNAL OF CANCER, Vol: 166, Pages: 38-40, ISSN: 0959-8049

Journal article

Yang JC-H, Schuler M, Popat S, Miura S, Park K, Passaro A, De Marinis F, Solca F, Maerten A, Kim ESet al., 2022, Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: An Updated Database of 1023 Cases Brief Report, FRONTIERS IN ONCOLOGY, Vol: 12, ISSN: 2234-943X

Journal article

Fendler A, Shepherd STC, Au L, Wilkinson KA, Wu M, Schmitt AM, Tippu Z, Farag S, Rogiers A, Harvey R, Carlyle E, Edmonds K, Del Rosario L, Lingard K, Mangwende M, Holt L, Ahmod H, Korteweg J, Foley T, Barber T, Emslie-Henry A, Caulfield-Lynch N, Byrne F, Shum B, Gerard CL, Deng D, Kjaer S, Song O-R, Queval C, Kavanagh C, Wall EC, Carr EJ, Namjou S, Caidan S, Gavrielides M, MacRae JI, Kelly G, Peat K, Kelly D, Murra A, Kelly K, O'Flaherty M, Shea RL, Gardner G, Murray D, Popat S, Yousaf N, Jhanji S, Van As N, Young K, Furness AJS, Pickering L, Beale R, Swanton C, Crick COVID19 consortium, Gandhi S, Gamblin S, Bauer DLV, Kassiotis G, Howell M, Nicholson E, Walker S, Wilkinson RJ, Larkin J, Turajlic S, CAPTURE consortiumet al., 2022, Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer., Cancer Cell, Vol: 40, Pages: 438-438, ISSN: 1535-6108

In this report from the CAPTURE study (NCT03226886), we demonstrate that a third dose of COVID-19 vaccine boosts neutralizing antibody (NAb) and cellular responses in patients with cancer, including those that had undetectable NAb titers (NAbT) following two vaccine doses or for whom NAbT waned. We have noted that one key member of the CAPTURE consortium—Sanjay Popat—was inadvertently not included in the author list. We now include him as a co-author. There are no additional changes to the declaration of interests statement, since Dr. Popat declares no competing conflict of interest. This author list change is now reflected in the online version of this letter.

Journal article

Popat S, Hsia T-C, Hung J-Y, Jung HA, Shih J-Y, Park CK, Lee SH, Okamoto T, Ahn HK, Lee YC, Sato Y, Lee SS, Mascaux C, Daoud H, Marten A, Miura Set al., 2022, Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon <i>EGFR</i> Mutations: A Retrospective International Cohort Study (UpSwinG), ONCOLOGIST, Vol: 27, Pages: 255-265, ISSN: 1083-7159

Journal article

Griesinger F, Cox O, Sammon C, Ramagopalan S, Popat Set al., 2022, Health technology assessments and real-world evidence: tell us what you want, what you really, really want Comment, JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, Vol: 11, Pages: 297-299, ISSN: 2042-6305

Journal article

Tiseo M, Popat S, Kim HR, Ahn M-J, Yang JC, Han J-Y, Hochmair MJ, Lee KH, Delmonte A, Garcia Campelo MR, Kim D-W, Griesinger F, Felip E, Califano R, Spira AI, Gettinger SN, Lin HM, Liu Y, Vranceanu F, Camidge Ret al., 2022, Brigatinib (BRG) vs crizotinib (CRZ) in anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor-naive ALK plus non-small cell lung cancer (NSCLC): ALTA-1L final results, European Lung Cancer Congress (ELCC), Publisher: ELSEVIER, Pages: S44-S45, ISSN: 0923-7534

Conference paper

Nastase A, Mandal A, Lu SK, Anbunathan H, Morris-Rosendahl D, Zhang YZ, Sun X-M, Gennatas S, Rintoul RC, Edwards M, Bowman A, Chernova T, Benepal T, Lim E, Taylor AN, Nicholson AG, Popat S, Willis AE, MacFarlane M, Lathrop M, Bowcock AM, Moffatt MF, Cookson WOCMet al., 2022, Integrated genomics point to immune vulnerabilities in pleural mesothelioma (vol 11, 19138, 2021), SCIENTIFIC REPORTS, Vol: 12, ISSN: 2045-2322

Journal article

O'Sullivan H, MacMahon S, Cui W, Milner-Watts C, Bhosle J, Davidson M, Minchom A, Yousaf N, O'Brien M, Popat Set al., 2022, Identification of EGFR exon 20 insertions: next generation sequencing is superior to PCR, Publisher: ELSEVIER IRELAND LTD, Pages: S31-S31, ISSN: 0169-5002

Conference paper

Popat S, Ramalingam S, Kim TM, Yang J, Riely G, Mekhail T, Nguyen D, Garcia Campelo MR, Felip E, Spira A, Piotrowska Z, Bazhenova L, Vincent S, Jin S, Griffin C, Diderichsen P, Gupta N, Bunn V, Lin J, Lin H, Churchill E, Mehta M, Zhou C, Janne Pet al., 2022, Mobocertinib (TAK-788) in epidermal growth factor receptor gene (EGFR) exon 20 insertion mutation-positive (EGFRex20ins+) metastatic non-small cell lung cancer (mNSCLC): results from the platinum-pretreated patients (PPP) cohort of a phase 1/2 study, Publisher: ELSEVIER IRELAND LTD, Pages: S30-S31, ISSN: 0169-5002

Conference paper

Sherlock S, Zhang YZ, Ly F, MacMahon S, Thompson L, Lim E, Popat S, Antoniou G, Robertus JL, Rice A, Brambilla C, Nicholson Aet al., 2022, Reducing fixation time significantly reduces failure rates: an audit of failure rates and turn-around times on next generation sequencing (NGS) of non-small lung carcinomas, Publisher: ELSEVIER IRELAND LTD, Pages: S1-S1, ISSN: 0169-5002

Conference paper

Mak K-M, McDonald F, Teague J, Faivre-Finn C, Forster M, Hanna G, Moinuddin S, Conibear J, Harden S, Popat S, Califano R, Farrelly L, Counsell N, Saron TMGet al., 2022, SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC), Publisher: ELSEVIER IRELAND LTD, Pages: S71-S71, ISSN: 0169-5002

Conference paper

McDonald F, Guckenberger M, Popat S, Faivre-Finn C, Andratschke N, Riddell A, Hanna G, Hiley C, Prakash V, Nair A, Diez P, Patel P, Kilburn L, Toms C, Bliss Jet al., 2022, HALT: targeted therapy with or without dose-intensified radiotherapy in oligo-progressive disease in oncogene addicted lung tumours, Publisher: ELSEVIER IRELAND LTD, Pages: S70-S71, ISSN: 0169-5002

Conference paper

Cui W, Milner-Watts C, McVeigh TP, Minchom A, Bholse J, Davidson M, Yousaf N, MacMahon S, Mugalaasi H, Gunapala R, Lee R, George A, Popat S, O'Brien Met al., 2022, A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancer, LUNG CANCER, Vol: 165, Pages: 34-42, ISSN: 0169-5002

Journal article

Popat S, Kim HR, Ahn M-J, Yang J, Han J-Y, Hochmair M, Lee KH, Delmonte A, Garcia Campelo M, Kim D-W, Griesinger F, Felip E, Califano R, Spira A, Gettinger S, Tiseo M, Lin H, Liu Y, Vranceanu F, Camidge Det al., 2022, Brigatinib vs crizotinib in ALK TKI-naive ALK plus NSCLC: final results from ALTA-1L, Publisher: ELSEVIER IRELAND LTD, Pages: S27-S28, ISSN: 0169-5002

Conference paper

Mencel J, Feber A, Begum R, Carter P, Smalley M, Bourmpaki E, Shur J, Zar S, Kohoutova D, Popat S, George A, McVeigh TP, Hubank M, Peckitt C, Fribbens CV, Watkins DJ, Rao S, Chau I, Cunningham D, Starling Net al., 2022, Liquid biopsy for diagnosis in patients with suspected pancreatic and biliary tract cancers: PREVAIL ctDNA pilot trial, ASCO Gastrointestinal Cancers Symposium, Publisher: LIPPINCOTT WILLIAMS & WILKINS, ISSN: 0732-183X

Conference paper

Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, Opitz I, Scherpereel A, Reck Met al., 2022, Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, ANNALS OF ONCOLOGY, Vol: 33, Pages: 129-142, ISSN: 0923-7534

Journal article

Coleman N, Harbery A, Heuss S, Vivanco I, Popat Set al., 2022, Targeting un-MET needs in advanced non-small cell lung cancer, LUNG CANCER, Vol: 164, Pages: 56-68, ISSN: 0169-5002

Journal article

Navani N, Baldwin DR, Edwards JG, Evison M, McDonald F, Nicholson AG, Fenemore J, Sage EK, Popat Set al., 2022, Lung Cancer in the United Kingdom, JOURNAL OF THORACIC ONCOLOGY, Vol: 17, Pages: 186-193, ISSN: 1556-0864

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: id=00557130&limit=30&person=true&page=4&respub-action=search.html